The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model

Gene Therapy, Published online: 09 December 2019; doi:10.1038/s41434-019-0116-1The deletion of mutant SOD1 via CRISPR/Cas9/sgRNA prolongs survival in an amyotrophic lateral sclerosis mouse model
Source: Gene Therapy - Category: Genetics & Stem Cells Authors: Source Type: research
More News: ALS | Gene Therapy | Genetics